Cefotetan-induced hemolytic anemia causing severe hypophosphatemia.
Phosphorus is a major component of proteins, phospholipids, and nucleotides. The increased uptake of phosphorus by cells during erythropoiesis can result in severe hypophosphatemia. A case of severe hypophosphatemia due to accelerated erythropoiesis in response to Cefotetan-induced hemolytic anemia is described. The hypophosphatemia seen during hemolysis may be the result, rather than the cause, of the hemolysis.
Division of Gastroenterology, Brown University, School of Medicine, Providence, Rhode Island.
S
S
Mohammed
S
S
Knoll
A
A
van Amburg
P A
PA
Mennes
D000743:Anemia, Hemolytic / Q000150:complications* / Q000209:etiology* / Q000503:physiopathology; D015313:Cefotetan / Q000009:adverse effects*; D004920:Erythropoiesis / Q000187:drug effects; D005260:Female; D006801:Humans; D017674:Hypophosphatemia / Q000209:etiology*; D008875:Middle Aged
D015313:Cefotetan